Pharmaceutical Business Review
The value includes a $1.55bn upfront payment and as much as $1.1bn in regulatory and commercial milestone payments.
Pharmaceutical Business Review
The value includes a $1.55bn upfront payment and as much as $1.1bn in regulatory and commercial milestone payments.
Pharmaceutical Business Review
The value includes a $1.55bn upfront payment and as much as $1.1bn in regulatory and commercial milestone payments.